Seaport Res Ptn Predicts TerrAscend Q1 Earnings

TerrAscend Corp. (OTCMKTS:TSNDF) – Research analysts at Seaport Res Ptn issued their Q1 2026 EPS estimates for TerrAscend in a note issued to investors on Sunday, March 9th. Seaport Res Ptn analyst S. Randhawa anticipates that the company will earn ($0.03) per share for the quarter. The consensus estimate for TerrAscend’s current full-year earnings is ($0.14) per share. Seaport Res Ptn also issued estimates for TerrAscend’s Q2 2026 earnings at ($0.03) EPS, Q3 2026 earnings at ($0.03) EPS and Q4 2026 earnings at ($0.03) EPS.

TerrAscend (OTCMKTS:TSNDF) last announced its quarterly earnings data on Thursday, March 6th. The company reported $0.01 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.04. The business had revenue of $74.35 million for the quarter, compared to analysts’ expectations of $72.37 million. TerrAscend had a negative net margin of 23.95% and a negative return on equity of 31.48%.

Separately, Atb Cap Markets cut shares of TerrAscend from a “strong-buy” rating to a “hold” rating in a report on Monday, December 9th.

TerrAscend Price Performance

Shares of TSNDF opened at $0.46 on Tuesday. The stock has a market cap of $133.63 million, a PE ratio of -1.63 and a beta of 1.64. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.69 and a current ratio of 1.35. TerrAscend has a fifty-two week low of $0.38 and a fifty-two week high of $2.20. The firm’s 50-day simple moving average is $0.56 and its two-hundred day simple moving average is $0.85.

TerrAscend Company Profile

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.